A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 3-WAY
CROSSOVER, MULTICENTER POLYSOMNOGRAPHY STUDY OF
PREGABALIN AND PRAMIPEXOLE IN ADULTS WITH RESTLESS LEGS
SYNDROME.
Summary
The purpose of this study is to evaluate the effect of the investigational use of an approved medication, pregabalin and pramipexole and placebo (an inactive substance) using sleep rating scales and sleep measurements in subjects with moderate to severe RLS that occur predominately in the evening.
How Can You Qualify?
Persons ages 18 and older with Restless Legs Syndrome symptoms occurring at least 2 to 3 days per week during the last 3 months. Qualified participants will receive at no cost; study related physical exams, study medication, study-related laboratory tests and compensation for time and travel.
Principal Investigator
AC Patel, MD
Contact
Mark Schrier
-
(570) 207-3945
or
mschrier@gminstitutes.com
Location
Sleep Lab of Northeastern Pennsylvania - Clarks Summit, Pennsylvania
